RADX logo

RADX
Radiopharm Theranostics Ltd - ADR

1,016
Mkt Cap
$55.05M
Volume
41,540.00
52W High
$16.25
52W Low
$3.62
PE Ratio
-1.58
RADX Fundamentals
Price
$4.66
Prev Close
$4.67
Open
$4.64
50D MA
$4.78
Beta
0.00
Avg. Volume
378,352.73
EPS (Annual)
-$3.43
P/B
1.59
$11.85
Loading...
Loading...
News
all
press releases
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Given Average Rating of "Moderate Buy" by Analysts
Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the four analysts that are presently covering...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Radiopharm Theranostics Signs Supply Deal With Siemens Healthineers For RAD101
(RTTNews) - Radiopharm Theranostics Ltd. (RADX) said Tuesday it has signed a supply agreement with Siemens Healthineers for RAD101, a novel imaging small molecule targeting fatty acid synthase (FASN) to diagnose suspected recurrent brain metastases from solid tumors...
Nasdaq News: Markets·4d ago
News Placeholder
Radiopharm Theranostics Shares RAD101 Phase IIb Update: 90% Hit Primary Endpoint in Brain Mets Study
Radiopharm Theranostics (NASDAQ:RADX) executives and clinical investigators highlighted new interim findings from the company's ongoing Phase IIb study of RAD101, a PET imaging tracer intended to...
MarketBeat·17d ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Given Average Rating of "Buy" by Brokerages
Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) have been given an average recommendation of "Buy" by the five analysts that are covering the firm...
MarketBeat·27d ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Update
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the recipient of a significant decline in short interest during the month of February. As of February 27th, there...
MarketBeat·1mo ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Given Consensus Rating of "Buy" by Brokerages
Shares of Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) have received a consensus rating of "Buy" from the five ratings firms that are currently covering the stock...
MarketBeat·2mo ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Up 112.6% in January
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) saw a significant growth in short interest in the month of January. As of January 30th, there was short interest...
MarketBeat·2mo ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Significant Decline in Short Interest
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a significant drop in short interest in the month of January. As of January 15th, there was short...
MarketBeat·2mo ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Sees Large Increase in Short Interest
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a large increase in short interest in December. As of December 31st, there was short interest...
MarketBeat·3mo ago
News Placeholder
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX) Short Interest Update
Radiopharm Theranostics Limited - Sponsored ADR (NASDAQ:RADX - Get Free Report) was the target of a large decrease in short interest in the month of December. As of December 15th, there was short...
MarketBeat·3mo ago
<
1
2
...
>

Latest RADX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.